Pharma News

GSK completes deal with Novartis and capital return £4bn

  • Posted on: 2 March 2015
  • By: PharmaTutor News

GlaxoSmithKline plc (GSK) announces that its three-part transaction with Novartis has completed today. As a result of this transaction, GSK has acquired Novartis’s global Vaccines business (excluding influenza vaccines) for an initial cash consideration of $5.25 billion; has created a new world-leading Consumer Healthcare joint venture with Novartis in which GSK will have majority control and an equity interest of 63.5%; and has divested its Oncology business for an aggregate cash consideration of $16 billion.

Vitamin D Reduces Lung Disease Flare-UPS

  • Posted on: 2 March 2015
  • By: PharmaTutor News

Vitamin D supplements can reduce chronic obstructive pulmonary disease (COPD) flare-ups by over 40 per cent in patients with a vitamin D deficiency, according to a new research. Researchers from Queen Mary University of London conducted a randomised trial on 240 patients with COPD in and around London. Half of the patients (122) received vitamin D supplements and the other half (118) received an equivalent placebo.

Ability of HIV to cause AIDS is Slowing: Study

  • Posted on: 2 March 2015
  • By: PharmaTutor News

The rapid evolution of HIV, which has allowed the virus to develop resistance to patients' immunity, is at the same time slowing the virus's ability to cause AIDS, according to a new research. The study also suggested that people infected by HIV are likely to progress to AIDS more slowly because of widespread access to antiretroviral therapy (ART).

Gut Microbes may Trigger Autoimmune Disease Later in Life

  • Posted on: 2 March 2015
  • By: PharmaTutor News

Researchers have found that the colonisation of the gut by certain types of bacteria may lead to immune responses later in life that are linked to autoimmune disease. Researchers in mice studies found that increases in the levels of segmented filamentous bacteria can trigger changes in the lymphoid tissue of the mouse gut that result in the production of antibodies that attack components of the cell nucleus.

Budget is Pro-People, Balanced, Growth-Oriented, Inclusive and Progressive: Shri J P Nadda

  • Posted on: 28 February 2015
  • By: PharmaTutor News

The Union Minister for health & Family Welfare, Shri J P Nadda has termed the Budget 2015-2016 announced by the Finance Minister today as balanced, progressive, pragmatic and pro-people. He said that the budget will lead to all around social and economic development that is inclusive and outcome oriented. The Health Minister has thanked the Hon. Prime Minister and the Finance Minister for the balanced and people-oriented Budget.

Pages